Background illustration for clinical trials search

Paid Clinical Trials Texas

Discover 4,978 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

for
Malignant Neoplasm
Location: Quebec, New Brunswick NJ, Montreal, Fairfax VA, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07247110

Phase1, Recruiting
Active & Responsive

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

for
Colorectal Cancer, Colorectal Cancer (CRC),
Location: Fairfax VA, Jacksonville FL, Atlanta GA,
Sponsor: Cartography Biosciences

Sex: All

Age: 18+

Code: NCT07321106

Phase1, Recruiting
Active & Responsive

PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)

for
Postoperative Pain, Acute
Location: Atlanta GA, Houston TX, Salt Lake City UT
Sponsor: Ensysce Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06602271

Phase3, Recruiting
Active & Responsive

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

for
Atopic Dermatitis (AD)
Location: New York NY, Norfolk VA, Wilmington NC, Camp Hill PA,
Sponsor: Enveda Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07298395

Phase2, Recruiting
Active & Responsive

Anabolic Response to Beef vs Plant Protein in (Pre)Frail Older Adults Using a Novel Stable Isotope Pulse Method

for
Protein Metabolism
Location: College Station TX
Sponsor: Texas A&M University

Sex: All

Age: 65 - 70+

Code: NCT07254403

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: New Haven CT, Philadelphia PA, Fairfax VA,
Sponsor: Ipsen

Sex: All

Age: 18+

Code: NCT07213817

Phase1, Phase2, Recruiting
Active & Responsive

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Lake Success NY, Wilmington DE, Orlando FL,
Sponsor: Ascendis Pharma A/S

Sex: All

Age: 2 - 17

Code: NCT07221851

Phase3, Recruiting
Active & Responsive

AMEND TS Early Feasibility Study

for
Symptomatic Functional MR 3 or Greater
Location: New York NY, Indianapolis IN, Houston TX,
Sponsor: Valcare Medical Ltd.

Sex: All

Age: 21+

Code: NCT06951672

Recruiting
Active & Responsive

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

for
AML With Gene Mutations
Location: New York NY, College Park MD, Chapel Hill NC,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06366789

Phase1, Recruiting
Active & Responsive

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Toronto, Grand Rapids MI, Nashville TN, Houston TX,
Sponsor: Ipsen

Sex: All

Age: 18+

Code: NCT07213830

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

for
Spasticity
Location: Elkins Park PA, Overland Park KS, Dallas TX, Downey CA
Sponsor: Ipsen

Sex: All

Age: 18 - 70

Code: NCT04752774

Phase1, Phase2, Recruiting
Active & Responsive

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

for
Non Small Cell Lung Cancer (NSCLC)
Location: Philadelphia PA, Dallas TX
Sponsor: Integro Theranostics

Sex: All

Age: 18+

Code: NCT07276789

Phase2, Recruiting
Active & Responsive

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

for
Phenylketonuria
Location: Pittsburgh PA, Tampa FL, Gainesville FL, Nashville TN,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT06971731

Phase3, Recruiting
Active & Responsive

ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

for
BAG3 Mutation Associated Dilated Cardiomyopathy
Location: Boston MA, Philadelphia PA, Cincinnati OH,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70

Code: NCT07218887

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

for
Rheumatoid Arthritis
Location: The Bronx NY, Chesapeake VA, Duncansville PA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07137598

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)

for
Niemann-Pick Type C Disease
Location: Fairfax VA, Rochester MN, Dallas TX, Calgary,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07082725

Phase3, Recruiting
Active & Responsive

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for
Congenital Adrenal Hyperplasia,
Location: Boston MA, New York NY, New Brunswick NJ,
Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All

Age: 1 - 17

Code: NCT07159841

Phase2, Phase3, Recruiting
Active & Responsive

Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy Type 1 (DM1)
Location: Richmond VA, Rochester NY, Gainesville FL,
Sponsor: Dyne Therapeutics

Sex: All

Age: 18 - 65

Code: NCT05481879

Phase1, Phase2, Recruiting
Active & Responsive

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

for
Acute Myeloid Leukemia, Pediatric AML
Location: Houston TX
Sponsor: Baylor College of Medicine

Sex: All

Age: 0 - 30

Code: NCT07059975

Early_phase1, Recruiting
Active & Responsive

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

for
Cystic Fibrosis
Location: Boston MA, Wilmington DE, Baltimore MD, Orlando FL,
Sponsor: Boston Children's Hospital

Sex: All

Age: 6+

Code: NCT06683092

Recruiting

Popular cities in Texas

With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.

Why choose Texas for clinical trials?

Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.

By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.

Common conditions studied in Texas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Texas